Workshops at BioTrinity 2012

Note: BioTrinity 2012 features workshops in sound-contained rooms within the Berkshire Stand, rather than within the Grandstand.

The workshops at BioTrinity 2012 will be more like roundtable discussions than seminars, and as organisers we demand that they are interactive. Participation at workshops is included in the conference registration fee, however as spaces are limited, pre-registered delegates are advised to sign up for workshops online and in advance via the online partnering system's Agenda Planner which is available to all registrants, to reserve their places. Workshops will be held over both full days of the conference, 25 - 26th April.  You will be able to walk in to join workshops at the start of their sessions, but pre-registered participants will take precendent over those who walk in ad hoc.

Full details of 2012 Workshops are listed below

Workshops Day 1: Wednesday, 25th April 2012 - Mandarin

13.30 - 14.00 Launch of Progressions - EY's Global Pharmaceutical Industry Report 2012
Hosted by Leo Gribben, Associate Partner, and Ian Oliver, Executive Director, Ernst & Young LLP
Abstract Life sciences companies face increasing pressure to demonstrate that they are helping patients adopt healthier behaviours and manage their diseases more effectively. Yet to thrive in this environment, companies will be required to fundamentally reinvent their business models to make them more patient-centric and better able to drive behavioural changes in consumers. We’ll discuss the trends accelerating a better understanding of patient behaviour, and invite you to discuss guiding principles to succeed in this new and changing environment, as summarized in our report. Copies will be available to take away.
14.00 - 15.00 Protecting Your Innovation
Hosted by Graham Lock, Partner, Michèle Richards, Patent Attorney and Caroline Carter, Patent Attorney, Fry Heath & Spence LLP
Abstract All companies have intellectual property and it is often amongst their most valuable assets. Given this, can you afford not to protect it? This workshop will cover topics of current interest relating to intellectual property protection, with reference to examples and a particular focus on protecting innovation in the field of biotechnology. Questions will be welcomed throughout the workshop and it is hoped that an interesting and informative discussion will ensue.
15.30 - 16:30 Getting Your Business Ready for Investment
Hosted by Keith Black, Partner, and Jonathan Uphoff, of counsel, Morgan Lewis & Bockius
Abstract Preparing your business for investment is not just about pleasing investors, it’s about positioning the business so that it is able to maximise from the benefits of that investment. Topics to be covered include: Investment terms, Due diligence, Structure of company, Stock options, Employee incentives.
16.30 - 17.00 Workshop available 
 
17.00 - 17.30 Workshop available 
 

Workshops Day 1: Wednesday, 25th April 2012 - Fred Winter

13.30 - 14.00 Essentials for Attracting and Retaining Top Talent
Hosted by Jayne McLaughlin, Director, and Neil Burns, Managing Director, george james ltd
Abstract For some early stage companies recruiting the right core talent can make or break the business not just in the development of the technology but also in attracting funding and maximising early commercial success. Even in well-established organisations senior level appointments have a significant effect on the future business success. However with the pressure on people’s time and financial resources it is all too easy to overlook some of the key points affecting this critical business issue.
This short presentation will highlight, based on over 50 man year of successful recruitment experience in this sector, the three key areas to consider in order to maximise the value of your recruitment activities.
14.00 - 15.00 Scottish Life Sciences Company Showcase
Hosted by David MacCallum, Senior Project Manager, Life Sciences Scotland
Abstract An opportunity to hear presentations from five up and coming Scottish Life Sciences companies. Ten minute presentations from each, in the areas of diagnostics, therapeutics and medical devices. 

     Cyclogenix Ltd, Duncan McGregor, CEO
     UBBiopharma Ltd, Bill Blair, Head of Business Creation, BioQuarter
     GTBiologics Ltd, Howard Marriage, Chairman
     SoftCell Medical Ltd, Alan Johnstone, CEO
     Sirakoss Ltd, Brian Butchart, CEO

15:30 - 16.00 What makes a company fundable?
Hosted by David Phillips, Partner, SR One
Abstract This workshop will examine the key criteria in the mind of the venture community (from SR One’s perspective) whenevaluating an investment in an early stage Life Science company. The focus will be on management, technology, strategy, structure and the dynamics of the deal. The workshop should provide a helpful checklist for entrepreneurs when attempting to raise funds or forming a company.
16.00 - 16.30 Carbon-14 Labelled Peptides - Solid Phase Peptide Synthesis, Biotinylation and PEGylation
Hosted by Sean Kitson, Investigator of Radiochemistry, Almac
Abstract The radiolabelling group at Almac1 have synthesised a number of peptide APIs containing carbon-14 amino acid residues using the solid phase peptide synthesis (SPPS) approach. A number of these carbon-14 labelled peptides were modified by the addition of polyethylene glycols (PEGs) to produce a new chemical entity with a different pharmacological profile. In some cases carbon-14 labelled peptides can undergo biotinylation to provide targeted drug substances. Two examples will be given to provide an overview of Solid Phase Peptide Synthesis (SPPS), PEGylation & Biotinylation towards the synthesis of carbon-14 labelled peptides.
16.30 - 17.00 Workshop available 
 
17.00 - 17.30 Workshop available 
 

 

Workshops Day 2: Thursday, 26th April 2012 - Mandarin

14.00 - 14.30 Taking the Pain out of Outsourcing - Maintaining the Safety, Quality and Efficacy of your Product
Andrew Kenyon, Technical Specialist, RSSL
Abstract In recent years the economic climate has increasingly impacted the resource available for internal analysis. Changing markets have seen an enhanced necessity for external regulatory knowledge and consultancy guidance, with a newfound dependence on outsourcing providers. Whether the requirement is from big pharma, virtual companies or university spin outs, the demand is for a reliable analytical partner who understands your priorities and can offer relevant support. So what needs to be considered to maintain the safety, quality and efficacy of your product; while ensuring the continued success of your business in changing times? Join us to find out.
14.30 - 15:00 Workshop available - Contact amanda.taylor@obn.org.uk
 
15.00 - 15.30 Workshop available - Contact amanda.taylor@obn.org.uk
 

 

Workshops Day 2: Thursday, 26th April 2012 - Fred Winter

13.30 - 14.30 Workshop available 
 
14.30 - 15.30 Technology Strategy Board -  Funding for Life Science Businesses?
Hosted by Zahid Latif, Head of Healthcare TSB
Abstract To be published shortly